000166051 001__ 166051
000166051 005__ 20240229123219.0
000166051 0247_ $$2doi$$a10.1016/j.devcel.2020.11.004
000166051 0247_ $$2pmid$$apmid:33232671
000166051 0247_ $$2ISSN$$a1534-5807
000166051 0247_ $$2ISSN$$a1878-1551
000166051 0247_ $$2altmetric$$aaltmetric:94804242
000166051 037__ $$aDKFZ-2020-02590
000166051 041__ $$aeng
000166051 082__ $$a610
000166051 1001_ $$0P:(DE-He78)876d213ee6559a5e98ddf2113698ed0b$$aHongu, Tsunaki$$b0$$eFirst author
000166051 245__ $$aAddicted to Acidic Microenvironment.
000166051 260__ $$aNew York, NY$$bElsevier$$c2020
000166051 3367_ $$2DRIVER$$aarticle
000166051 3367_ $$2DataCite$$aOutput Types/Journal article
000166051 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1609151208_26911
000166051 3367_ $$2BibTeX$$aARTICLE
000166051 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000166051 3367_ $$00$$2EndNote$$aJournal Article
000166051 500__ $$a#EA:A010#LA:A014#
000166051 520__ $$aAcidic pH levels are often observed in growing tumors, with profound effects on cancer cells and surrounding microenvironment. In this issue of Developmental Cell, Funato et al. (2020) show that expression of oncogenic phosphatase of regenerating liver 3 (PRL3) shifts cellular preference for environmental pH, leading to acid addiction.
000166051 536__ $$0G:(DE-HGF)POF3-311$$a311 - Signalling pathways, cell and tumor biology (POF3-311)$$cPOF3-311$$fPOF III$$x0
000166051 588__ $$aDataset connected to CrossRef, PubMed,
000166051 7001_ $$0P:(DE-He78)ee36a00803235200292c3488043cfd68$$aOskarsson, Thordur$$b1$$eLast author
000166051 773__ $$0PERI:(DE-600)2053870-4$$a10.1016/j.devcel.2020.11.004$$gVol. 55, no. 4, p. 381 - 382$$n4$$p381 - 382$$tDevelopmental cell$$v55$$x1534-5807$$y2020
000166051 909CO $$ooai:inrepo02.dkfz.de:166051$$pVDB
000166051 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)876d213ee6559a5e98ddf2113698ed0b$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000166051 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ee36a00803235200292c3488043cfd68$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000166051 9131_ $$0G:(DE-HGF)POF3-311$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vSignalling pathways, cell and tumor biology$$x0
000166051 9141_ $$y2020
000166051 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bDEV CELL : 2018$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-08-21
000166051 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bDEV CELL : 2018$$d2020-08-21
000166051 9201_ $$0I:(DE-He78)A010-20160331$$kA010$$lA010 Stammzellen und Krebs$$x0
000166051 9201_ $$0I:(DE-He78)A014-20160331$$kA014$$lA014 Metastatische Nischen$$x1
000166051 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000166051 980__ $$ajournal
000166051 980__ $$aVDB
000166051 980__ $$aI:(DE-He78)A010-20160331
000166051 980__ $$aI:(DE-He78)A014-20160331
000166051 980__ $$aI:(DE-He78)HD01-20160331
000166051 980__ $$aUNRESTRICTED